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Abstract Absolute quantification of peptides is typically
achieved using amino acid analysis, elemental analysis or
derivatisation chemistry. Impurities, if present, may be
accounted for using analytical high-performance liquid chro-
matography (HPLC) with detection of the peptide bond ultra-
violet (UV) absorbance. To do this, peak areas from a UV
chromatogram are used to estimate percentage purity on a
mass basis, and this purity value is used as a correction.
However, because the approach assumes that UVabsorbance
is uniformly proportional to mass, the result may be only
semi-quantitative. Here, an alternative approach involving
HPLC with detection of intrinsic tyrosine fluorescence is de-
scribed. The fluorescence properties of a 21-residue synthetic
peptide corresponding to an S-carbamidomethylated tryptic
fragment of human serum albumin were characterised, and a
method involving quantification relative to a non-peptidic
calibrant, N-acetyl-L-tyrosine ethyl ester, was established.
The method was used to quantify the thiol form of the peptide,
and the results were compared with a parallel analysis involv-
ing derivatisation of the same material with Ellman’s reagent.
When differences in fluorescence response (analyte versus
calibrant) were accounted for, the measurements obtained
via the two methods were in good agreement. Contributions
from peptidic impurities were also considered, and their influ-
ence on the validity of the conclusions was evaluated. Despite
some ambiguities introduced by the impurities, and the iden-
tification of some other potential sources of error, the results
demonstrate that use of Tyr fluorescence is a promising solu-
tion to the challenging problem of absolute peptide
quantification.
Keywords Amino acids/peptides . Genomics/proteomics .
HPLC . Fluorescence/luminescence
Introduction
For quantitative studies employing synthetic peptides (e.g. as
ligands [1] or standards [2]), an assay is useful for determining
the starting peptide concentration. Typical assays involve deg-
radation analysis (e.g. elemental analysis [2, 3] or amino acid
analysis [2, 3]) or chemical derivatisation (e.g. reaction with
fluorescamine [4]) followed by spectroscopic determination.
Alternatively, if present, the intrinsic UV-absorbing properties
of tyrosine (Tyr) and/or tryptophan can be exploited to achieve
a similar goal [1]. Of course, if sufficient material is available,
quantification might be achieved by simple weighing, but the
contributions of peptidic [5] and non-peptidic [6] impurities
must be taken into account. Purity must also be considered
when using degradation analysis or spectroscopy because
peptidic impurities can contribute additionally to the observed
signal. Analytical high-performance liquid chromatography
(HPLC) with short-wavelength UV detection (HPLC-UV) is
the preferred method for assessing purity because of its ability
to detect and resolve impurities [6]. The resulting chromato-
gram is integrated, and the peak area due to the peptide of
interest is expressed as a percentage of the total area for all
peaks. This is undoubtedly a convenient method, but the
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estimates it generates cannot necessarily be applied directly to
the material’s mass; to do so would require the peak area to be
uniformly proportional to mass for all components (i.e. pep-
tide of interest, peptidic impurities and non-peptidic impuri-
ties), and this assumption is not always valid [7].
It would be useful if a peptide could be quantified directly,
without having to correct for impurities that may or may not
have been adequately characterised. It would also be useful if
the reference standard for the method were non-peptidic, be-
cause this would allow the uncertainties described above to be
completely eliminated from the analysis. To these ends, some
promising results have been obtained using HPLCwith online
chemical oxidation and mass spectrometry [7] or using HPLC
with detection of labelled [8] or unlabelled [9] peptides by
inductively coupled plasma mass spectrometry (ICP-MS).
These methods are sensitive but might not be appropriate in
all cases: the chemical oxidation method requires specialised
instrumentation, whilst ICP-MS can only be used for
unlabelled peptides if they contain phosphorus, sulfur or
selenium.
As an alternative, we explored the possibility of using
HPLC with detection of intrinsic Tyr fluorescence (HPLC-
FDTyr). By analogy with the ICP-MS approaches, we en-
visaged benefits from employing a generic (i.e. non-pep-
tidic) fluorescence calibrant for quantifying peptides. A
similar idea, albeit based on UV absorption rather than
fluorescence, underlies methods for predicting the molar
extinction coefficients (ε) of proteins [10, 11]: using only
sequence information and the ε values of model com-
pounds, ε values of proteins have been predicted with a
good degree of accuracy. One such small molecule used
for this purpose was N-acetyl-L-tyrosine ethyl ester (Ac-
Tyr-OEt) [11, 12], in which the amino and carboxylic acid
groups of Tyr are blocked. In the present work, it was
hypothesised that Ac-Tyr-OEt would recapitulate not only
the UV-absorbing properties of a Tyr residue in a peptide
but also the fluorescence. Furthermore, according to the
‘generic calibrant’ idea, we considered that it might be
possible to predict peptide concentrations using a known
functional relationship between Ac-Tyr-OEt concentration
and fluorescence response.
The method described herein was developed to address a
specific need, namely the quantification of a peptide deriva-
tive with sequence ALVLIAFAQYLQQCPFEDHVK, in
which cysteine (Cys) is carbamidomethylated and valine is
fully labelled with 13C and 15N. This structure, which is
henceforth referred to as Cam-iT3, is a labelled analogue of
product T3 from tryptic digestion of human serum albumin
[13]. Cam-iT3 is used as an internal standard in a recently
developed adductomics workflow [13], and is prepared by
reacting the corresponding peptide thiol (iT3) with
iodoacetamide. Results for both Cam-iT3 and unmodified
iT3 highlight potential advantages over the existing methods
for peptide quantification, and represent a basis from which
more general methodologies might be developed.
Materials and methods
Materials
HPLC-grade acetonitr i le, HPLC-grade water and
tris(hydroxymethyl)aminomethane (Tris) were purchased
from Fisher Scientific (Loughborough, UK); Ac-Tyr-OEt
monohydrate (purity, HPLC 99.3 %, water content, Karl
Fischer titration 5.94 %) was purchased from Santa Cruz
Biotechnology (Heidelberg, Germany); dimethylsulfoxide
(DMSO), 5,5′-dithiobis(2-nitrobenzoic acid) (DTNB), formic
acid, reduced L-glutathione (GSH; purity, HPLC 99.3 %, pu-
rity, iodine titration 99 %) and iodoacetamide were purchased
from Sigma-Aldrich (Dorset, UK); hydrochloric acid was pur-
chased from VWR International (Leicestershire, UK); poly-
styrene 96-well plates were purchased from Greiner Bio One
(Gloucester, UK); iT3 (ALVLIAFAQYLQQCPFEDHVK, in
which valine is fully labelled with 13C and 15N; HPLC-UV
purity>95 %) was purchased from a commercial source (de-
tails available from the authors on request).
Reversed-phase HPLC
Reversed-phase HPLC was carried out using an Agilent 1100
system consisting of a binary pump, an online de-gasser, a
manual injection valve, a heated column compartment, a di-
ode array detector (DAD) and a fluorescence detector (FD).
Eluent A was 0.1 % (v/v) aqueous formic acid and eluent B
was 0.1 % (v/v) formic acid in acetonitrile. For quantitative
analyses, injections were performed by overfilling a 50- or
20-μL sample loop with at least three volumes of sample.
For qualitative analyses, the loop size was 100 μL or 1 mL
and a partial-fill method was used. In all cases, the stationary
phase was C5-functionalised silica with a particle size of 5 μm
(Supleco BIO Wide Pore, Sigma-Aldrich Co. Ltd, Dorset,
UK). Various different packed columns were used, either in-
dividually or in pairwise combinations depending on the re-
quirements of the analysis (see Table 1). The column temper-
ature was 25 °C, the flow rate was 1.5 mL−1 and, unless
otherwise stated, all substances were eluted isocratically at
30 % of eluent B. The DAD was used to monitor UV absor-
bance of the column effluent at two fixed wavelengths (210
and 278 nm). For HPLC-FDTyr, detection of Tyr fluorescence
was achieved using an excitation wavelength (λex) of 278 nm,
an emission wavelength (λem) of 312 nm and a PMT gain of
10. Chromatograms were analysed in Agilent ChemStation
using auto-integration where possible. In cases where chro-
matographic irregularities prevented the use of auto-integra-
tion, a peak area was taken as the mean from three manual
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integrations. Absorption and fluorescence spectra were ac-
quired using the DAD and the FD, respectively. For fluores-
cence emission scanning, λex was 278 nm; for fluorescence
excitation scanning, λem was 312 nm. For each substance,
spectra recorded over a range of relevant retention times (the
full peak width at half-maximum height) were averaged in
ChemStation. Fraction collection was performed manually
on the basis of real-time absorbance measurements at the
DAD. The time offset between the DAD and the fraction
collection was determined using a tracer substance (2-nitro-
5-thiobenzoic acid).
Mass spectrometry
Electrospray ionisation mass spectrometry (ESI-MS) was
used for the characterisation of Cam-iT3 and for the identifi-
cation of peptidic impurities in the commercial iT3 prepara-
tion. HPLC fractions containing the peptide(s) of interest were
infused at 10 μL min−1 (syringe pump) into the ESI source of
a Thermo LTQ-XL linear ion trap mass spectrometer (Thermo
Fisher Scientific, Hemel Hempstead, UK). Samples were
ionised in positive mode using a capillary temperature of
300 °C, a capillary voltage of 19 V, a spray voltage of 4 kV
and a sheath gas (nitrogen) flow rate of 8 arb. units. The ion
trap was operated under 2.3 × 10−5 Torr of helium, which
functioned as both the damping gas and the collision gas
(see below). For tandem mass spectrometry (MS/MS), the
isolation width was 1 m/z, and collision-induced dissociation
was achieved using a normalised collision energy of 20 %.
Spectra were acquired and evaluated using the Xcalibur soft-
ware (Thermo Fisher Scientific).
Preparation of Cam-iT3
Cam-iT3 was prepared essentially as described by Li et al.
[13]. Full details and characterisation data can be found in
the Electronic Supplementary Material (ESM).
Preparation of Ac-Tyr-OEt standard solutions
Ac-Tyr-OEt monohydrate was dissolved at 10 mM in a 30 %
(v/v) aqueous solution of acetonitrile containing 0.1 % (v/v)
formic acid. Using the same acidified acetonitrile solution as a
diluent, two sets of replica standards were prepared indepen-
dently from the 10-mM stock.
Estimation of lower limits of linear dynamic ranges
Eight concentrations of Ac-Tyr-OEt were analysed using
HPLC-UV278-FDTyr (i.e. HPLC with simultaneous detection
of UV278 and Tyr fluorescence; see ESM Figures S3 and S4).
UV278 and FDTyr peak areas for the four most concentrated
standards (5, 10, 20 and 50 μM) were plotted as functions of
concentration, and in each case, linearity was confirmed using
ordinary least squares (OLS) linear regression analysis (see
ESM). The equations of the regression lines were used to
predict peak areas for the lower concentration range (1 μM,
500 nM, 100 nM and 10 nM), and the deviations of the ob-
served values from the expected values were used to calculate
percentage errors. The lower limit of linearity was taken as the
concentration below which the error became greater than 5 %.
Determination of relative fluorescence responses
The relative fluorescence response of a substance (Rsubstance) is
defined according to Eq. 1, in which the peak area terms refer
to HPLC-UV278-FDTyr data from one or more injections. In
practice, two slightly differentmethodswere used: for Ac-Tyr-
OEt, the FDTyr peak areas for four concentrations were
regressed on their corresponding UV278 peak areas (OLS lin-
ear regression), and RAc-Tyr-OEt was taken as the slope of the
regression line; for the peptides, only the highest available
concentrations were analysed, and Rpeptide (i.e. RCam-iT3 or
RiT3) was taken as the mean from three replicates.
Table 1 Column assemblies
used for reversed-phase HPLC of
peptides and Ac-Tyr-OEt
Column assembly Column 1a Column 2a
Product no. Length (mm) I.D. (mm) Product no. Length (mm) I.D. (mm)
A 568472-U 20 4.0 568421-U 100 4.6
B 568472-U 20 4.0 – – –
C 568472-U 20 4.0 568420-U 50 4.6
D 568421-U 100 4.6 – – –
E 568423-U 250 4.6 – – –
F 568472-U 20 4.0 568472-U 20 4.0
Product numbers correspond to entries in the Sigma-Aldrich catalogue
I.D. inner diameter
a For pairwise combinations, numbering corresponds to the order of serially connected columns in the direction of
flow
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Rsubstance ¼ FDTyr peakareaUV278 peakarea ð1Þ
Quantification of Cam-iT3 relative to Ac-Tyr-OEt
In order to obtain comparable UV278 and FDTyr responses for
Ac-Tyr-OEt and Cam-iT3, conditions in the detectors’ flow
cells had to be kept constant across all measurements (hence
isocratic elution of all substances with the same mobile
phase). Under these conditions, however, no one column as-
sembly performed well for both substances. Therefore, an
approach was taken whereby an optimal assembly was con-
figured for each substance, and the assemblies were manually
switched or reconfigured according to the substance under
analysis. Thus, for quantification of Cam-iT3, the first step
was to analyse a set of Ac-Tyr-OEt standards (5, 10, 20 and
50 μM) using column assembly A (see Table 1). Next, the
peptide solution of unknown concentration was analysed in
triplicate using column assembly B. Finally, to account for any
instrumental drift, the second set of Ac-Tyr-OEt standards was
analysed, again using column assembly A. OLS linear regres-
sion and associated statistical tests were used to determine the
functional relationship between Ac-Tyr-OEt concentration
and FDTyr response (see ESM). Further analytical procedures
are described in ‘Results and Discussion’.
Testing for adsorptive losses of Ac-Tyr-OEt and Cam-iT3
in HPLC-FDTyr
Each substance was chromatographed on a pair of relevant
column assemblies (assemblies D and E for Ac-Tyr-OEt,
assemblies B and F for Cam-iT3; see Table 1). All concen-
trations were within the method’s linear dynamic range.
For each substance/assembly, the FDTyr responses from
multiple injections (n ≥ 3) were measured. The analyses
were blocked according to substance, but randomised with
respect to column assembly. If a lower mean response was
observed for a longer column (i.e. implying loss), the sig-
nificance of the result was tested using a one-tailed inde-
pendent samples t test in Microsoft Excel 2010. On the
basis of additional results obtained in our laboratory (data
not shown), other potential sources of loss (e.g. adsorption
to vials and tubing) were assumed to be insignificant.
Proof of principle using independent assays
iT3 was quantified relative to GSH using a microplate as-
say based on the method of Ellman [14]. This assay was
developed so that GSH and iT3 could be analysed under
mutually compatible conditions. Stock solutions of iT3
were prepared in DMSO, and GSH standard solutions were
prepared in a degassed 1:1 mixture of Tris-HCl buffer
(0.1 M, pH 8.0) and acetonitrile. Two replica sets of stan-
dards (12.5, 25, 50, 75 and 100 μM) were prepared, with
each set derived from an independent weighing of solid
GSH. In a 96-well microplate, the GSH standards and the
iT3 stocks were combined with appropriate diluents
(DMSO and/or Tris-buffered acetonitrile solution) so that
all solutions had the same final volume (100 μL) and the
same composition (nine parts buffer, nine parts acetonitrile
and two parts DMSO). Thiol groups were derivatised by
adding 100 μL of 0.5 mg mL−1 DTNB, equilibrated at pH
8.0 in Tris-buffered acetonitrile solution, to each well. The
microplate was covered, incubated at ambient temperature
for 5 min and then analysed spectrophotometrically at
405 nm using a Biotek ELx800 plate reader (BioTek
Instruments, Inc., Bedfordshire, UK). In the absence of
DTNB, neither iT3 nor GSH had any significant absor-
bance at 405 nm, indicating that the raw absorbance data
did not need to be corrected. The functional relationship
between GSH concentration and absorbance was established
using OLS linear regression (see ESM), and the equation of
the regression line was used to predict the concentrations of
three iT3 stocks (different concentrations but same order of
magnitude) that had each been analysed in triplicate (coeffi-
cient of variation<3 %). For the corresponding HPLC-FDTyr
measurements, the stocks were diluted 100 times into 30% (v/
v) aqueous acetonitrile containing 0.1 % (v/v) formic acid and
analysed as described for Cam-iT3.
Characterisation of peptidic impurities
Approximately 10 μg of the iT3 preparation was analysed
via HPLC-FDTyr with offline ESI-MS. For this particular
purpose, column assembly C provided optimal separation
and peak definition. Fractions of HPLC effluent containing
fluorescent material were infused directly into the mass
spectrometer as described above. Putative peptide peaks
were resolved in selected ion monitoring mode, and charge
states were assigned on the basis of peak separation in the
isotopic ion cluster. Based on the putative monoisotopic
signals, initial assignments were made by identifying
matches from a list of values calculated for plausible im-
purities (see ESM). Assignments for which the calculated
m/z was within ±0.2 m/z of the observed value were sub-
mitted for validation using MS/MS data. The m/z values of
all fragment ions with relative abundance >2 % were
checked against a list of calculated values comprising the-
oretical peptide backbone fragments (singly, doubly and
triply protonated a-, b-, y- and z-type product ions [15]).
Assignments for which the calculated m/z was within ±0.5
m/z of the observed value were used to verify parts of the
sequence, and the candidate sequence best represented by
the data was selected as the likely identity of the substance.
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Results and discussion
The choice of Ac-Tyr-OEt as the calibrant was motivated
by a report from Edelhoch [12], who observed very similar
ε275.5 values for Ac-Tyr-OEt and Gly-Tyr-Gly (1500 and
1470 M−1 cm−1, respectively). This implied that a known
relationship between Ac-Tyr-OEt concentration and UV
response could be used to predict peptide concentrations
(and vice versa). The error on this type of estimate would
be equivalent to the difference in ε (approximately 2 %),
and could be reduced by making the appropriate correc-
tion. For the present study, these principles seemed equally
applicable to Cam-iT3, which also contains a single Tyr
residue. It was considered that if the substances’ quantum
yields of fluorescence were also equivalent, Ac-Tyr-OEt
would recapitulate the fluorescence of Cam-iT3 as well.
This reasoning led to an initial hypothesis: that a known
relationship between Ac-Tyr-OEt concentration and FDTyr
response could be used to predict peptide concentrations.
Typically, such a relationship is established using OLS lin-
ear regression analysis, and predictions are made using the
equation of the regression line. Equation 2 therefore sum-
marises the initial hypothesis using relevant variables and
regression coefficients: rpeptide is the FDTyr response of the
peptide analyte, mAc-Tyr-OEt is the slope of a regression line
for response on concentration, bAc-Tyr-OEt is the y-intercept
and cpeptide is the predicted concentration.
cpeptide ¼ rpeptide− bAcTyrOEtmAcTyrOEt ð2Þ
As a first test, the two substances were analysed in a
series of UV/visible and fluorescence scanning experi-
ments. Each substance was chromatographed using
isocratic elution with the same mobile phase (30 % of el-
uent B), and spectra were recorded using the DAD and the
FD. Cam-iT3 and Ac-Tyr-OEt displayed near-identical
maxima in their absorbance, fluorescence excitation and
fluorescence emission spectra (Fig. 1). The absorption
maxima were consistent with relevant examples from the
literature [11, 16]. The fluorescence emission maxima were
9 nm higher than a literature example (Leu-Tyr-Leu), prob-
ably as a result of differences in the conditions under which
the measurements were made.
Next, the fluorescence responses of Cam-iT3 and Ac-Tyr-
OEt were compared. Assuming that ε278 (i.e. the value of ε at
the measured wavelength of maximum absorbance) would be
constant across all substances, relative responses (Rsubstance)
were calculated from UV278 and FDTyr peak area data as de-
scribed in ‘Materials and Methods’. Using R-values, it was
then possible to test the validity of the initial hypothesis. For
the hypothesis to be supported, a ratio of these values, RAc-Tyr-
OEt/RCam-iT3, should equal unity: if RAc-Tyr-OEt/RCam-iT3 < 1,
Eq. 2 would overestimate cpeptide; conversely, if RAc-Tyr-OEt/
RCam-iT3>1, cpeptide would be underestimated. The ratio deter-
mined for Cam-iT3 was 0.342, meaning that the initial hy-
pothesis was not supported because Cam-iT3 was more fluo-
rescent than Ac-Tyr-OEt. In the absence of literature data from
directly comparable systems, we do not attempt to rationalise
this result here, but we acknowledge that it is sufficiently
interesting to warrant further investigation.
It was now considered that the prediction accuracy could
be improved by applying RAc-Tyr-OEt/Rpeptide as a correction
factor. This formed the basis of a modified hypothesis based
on the use of Eq. 3 to obtain cpeptide.
cpeptide ¼ rpeptide−bAcTyrOEtmAcTyrOEt 
RAcTyrOEt
RCamiT3
ð3Þ
In implementing the above concepts, Ac-Tyr-OEt standard
concentrations (5 to 50 μM) were selected based on the ex-
pected concentration of purified Cam-iT3 in the HPLC efflu-
ent (20 μM). The fluorescence response was linear over the
concentration range of interest (see ESM), but became non-
linear below 5 μM. From this result alone, HPLC-FDTyr did
not appear to offer any advantage over a simpler HPLC-UV278
method, but clear benefits were observed when small amounts
of peptide were analysed: in addition to higher sensitivity (see
ESM Fig. S9), HPLC-FDTyr also provided more reproducible
peak areas when the peptide concentration was near the lower
limit of the linear dynamic range (e.g. coefficient of variation
for triplicate analysis, 0.9 % for HPLC-FDTyr versus 6.4 % for
HPLC-UV278).
Next, the validity of the ‘generic calibrant’ approach was
considered from a practical point of view. Given that the
Fig. 1 Absorption and fluorescence spectra of aAc-Tyr-OEt and bCam-
iT3. Normalised intensity is relative to the peak of interest. For the
fluorescence excitation spectrum (dashed line), λem was 312 nm; for
the emission spectrum (solid line), λex was 278 nm
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method uses different column assemblies and fluorescent sub-
stances interchangeably, analyte-sorbent interactions repre-
sented a potential source of error. Specifically, it was
hypothesised that an analyte could be lost to the stationary
phase by adsorption, resulting in an inverse relationship be-
tween FDTyr response and column length. To test this, the
effect of column assembly on FDTyr response was measured
for each substance. For Ac-Tyr-OEt, increasing the column
length by 150 % (assembly D→ assembly E) did not cause
any reduction in the FDTyr response. For Cam-iT3, doubling
the length (assembly B→ assembly F) caused the chromato-
graphic peak to broaden considerably, making it difficult to
assign a baseline. The mean response was slightly dampened
(−3.8 %), but this was not statistically significant (one-tailed
independent samples t test, P>0.1). Hence, it appeared that
analyte-sorbent interactions should not be a source of error.
As an overall test of the modified hypothesis, a set of con-
centrations predicted using Eq. 3 were compared to an inde-
pendent set of predictions for the same samples but obtained
via a different method (Ellman assay [14]). Since the Ellman
assay quantifies thiol groups, the unmodified commercial iT3
peptide was used instead of Cam-iT3. The fluorescence re-
sponse of iT3 (RAc-Tyr-OEt/RiT3 = 0.348) was similar to that of
Cam-iT3, and apart from interacting more strongly with the
stationary phase, its chromatographic behaviour was also sim-
ilar. The concentrations of three iT3 solutions predicted from
Tyr fluorescence (199, 393 and 612 μM) agreed well with
corresponding predictions from the Ellman assay (199, 408
and 613 μM, respectively). In the FDTyr chromatograms of
iT3, however, we noticed three extraneous peaks (Fig. 2a,
peaks E1, E2 and E3), which we investigated further. It was
considered that these peaks might be due to peptidic impuri-
ties related to iT3 (e.g. deletion sequences [5, 6]), which could
potentially interfere with validation. For example, if an amino
acid residue other than Cys or Tyr were deleted, one might
observe a false positive response in the Ellman assay and an
extraneous peak in HPLC-FDTyr. The FDTyr response could be
corrected by including the area under the extraneous peak, but
this would require the impurity’s R-value to be known.
After using offline ESI-MS to confirm that the major chro-
matographic component was iT3 (Fig. 2b, ESM Fig. S12a and
Table S6), attention was focused on the major extraneous peak
(E3). Noting that, like iT3, this component was accompanied
by a putative peptide bond UV response (ESM Fig. S10), we
conducted further analyses using offline ESI-MS andMS/MS.
Two [M+3H]3+ ions corresponding to peptidic impurities
were identified in the eluate (Fig. 2b, ESM Fig. S12 and
Table S6): one was lighter than iT3 (m/z=777.3) and the other
was heavier (m/z=858.3). iT3 itself (m/z=815.6) was also
observed in the same fraction, probably from the tail of the
major chromatographic peak. The light impurity was 115 Da
lighter than iT3, suggesting deletion [5, 6] of aspartic acid.
This finding was supported by MS/MS analysis (ESM
Fig. S13a), which localised the missing 115 Da to within an
eight-residue sequence at the C- terminus of iT3
(CPFEDHVK). The heavy impurity was 128 Da heavier than
iT3, suggesting insertion [5, 6] of an additional amino acid
residue (glutamine or lysine). The MS/MS data were consis-
tent with an iT3 analogue in which the internal sequence
LQQC had been expanded to LQQQC (see ESM
Fig. S13b). Despite observing no evidence of peptide bonds
for E1 or E2 (ESM Fig. S10), these minor components were
also checked using offline ESI-MS (ESM Fig. S11). No pep-
tidic substances were detected under E1, but under E2, we
found three more putative peptides. One of these (m/z 792.4;
ESM Figs. S11 and S12b) was unambiguously identified
by MS/MS as a deletion sequence lacking the N-terminal al-
anine residue (ESM Fig. S14). The important thing to note
about the peptidic impurities is that they all contain cyste-
ine. Thus, a proportion of the extraneous FDTyr responses
could be linked to false positive responses in the Ellman
assay. Since the impurities’ UV278 responses were all too
Fig. 2 Analysis of fluorescent
components in a commercial
preparation of iT3: a
chromatogram from HPLC-
FDTyr. iT3 accounts for the
majority of the observed
fluorescence, but extraneous
peaks (E1–E3) were also present.
In this experiment, two fractions
(1 and 2) were collected. b ESI
mass spectra from infusion of the
two fractions. Components E1
and E2 were analysed in a
separate experiment (see ESM)
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low for specific R-values to be calculated, the only way of
correcting for them was to assume uniform R across all
substances (i.e. Rimpurity =RiT3). When the appropriate cor-
rections were applied, the HPLC-FDTyr results appeared to
overestimate the concentration of relevant peptides by ap-
proximately 22 %. Considering the assumption regarding
Rimpurity, however, the magnitude of this error should be
interpreted with caution.
Conclusions
A fluorescence-based method for quantifying Cam-iT3, a
Tyr-containing peptide derived from the sequence of hu-
man serum albumin, has been developed and tested.
Using the method, it was demonstrated that the concen-
tration of Cam-iT3 (or iT3, a related peptide) could be
readily estimated, even in the presence of peptidic impu-
rities. Unfortunately, however, these impurities interfered
with attempts to fully validate the method. The available
data suggest that the ‘generic calibrant’ approach might
fractionally overestimate the true peptide concentration,
and further development may be required to improve its
accuracy. Despite this apparent limitation, the approach
still offers advantages over many of the methods used
routinely for peptide quantification. Moreover, it is antic-
ipated that a general method for the quantification of pep-
tides with intrinsic fluorescence could emerge from this
work.
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